Trounson A - Search Results

1

Sir Ian Wilmut 1944-2023.

Trounson A, Cibelli J. Trounson A, et al. Nat Biotechnol. 2023 Nov;41(11):1515-1516. doi: 10.1038/s41587-023-02009-x. Nat Biotechnol. 2023. PMID: 37845571 No abstract available.

2

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy.

Shu R, Hammett M, Evtimov V, Pupovac A, Nguyen NY, Islam R, Zhuang J, Lee S, Kang TH, Lee K, Nisbet I, Hudson P, Lee JY, Boyd R, Trounson A. Shu R, et al. Among authors: trounson a. Bioeng Transl Med. 2023 Jul 10;8(6):e10571. doi: 10.1002/btm2.10571. eCollection 2023 Nov. Bioeng Transl Med. 2023. PMID: 38023726 Free PMC article.

3

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies.

To V, Evtimov VJ, Jenkin G, Pupovac A, Trounson AO, Boyd RL. To V, et al. Among authors: trounson ao. Front Immunol. 2022 Aug 18;13:968395. doi: 10.3389/fimmu.2022.968395. eCollection 2022. Front Immunol. 2022. PMID: 36059451 Free PMC article. Review.

4

Why it is important to study human-monkey embryonic chimeras in a dish.

De Los Angeles A, Regenberg A, Mascetti V, Benvenisty N, Church G, Deng H, Izpisua Belmonte JC, Ji W, Koplin J, Loh YH, Niu Y, Pei D, Pera M, Pho N, Pinzon-Arteaga C, Saitou M, Silva JCR, Tao T, Trounson A, Warrier T, Zambidis ET. De Los Angeles A, et al. Among authors: trounson a. Nat Methods. 2022 Aug;19(8):914-919. doi: 10.1038/s41592-022-01571-7. Nat Methods. 2022. PMID: 35879609 Free PMC article.

5

'Off-the-Shelf' Immunotherapy: Manufacture of CD8⁺ T Cells Derived from Hematopoietic Stem Cells.

Boyd N, Cartledge K, Cao H, Evtimov V, Pupovac A, Trounson A, Boyd R. Boyd N, et al. Among authors: trounson a. Cells. 2021 Oct 2;10(10):2631. doi: 10.3390/cells10102631. Cells. 2021. PMID: 34685611 Free PMC article.

6

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy.

Islam R, Pupovac A, Evtimov V, Boyd N, Shu R, Boyd R, Trounson A. Islam R, et al. Among authors: trounson a. Cells. 2021 Apr 29;10(5):1058. doi: 10.3390/cells10051058. Cells. 2021. PMID: 33946954 Free PMC article. Review.

7

Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer.

Shu R, Evtimov VJ, Hammett MV, Nguyen NN, Zhuang J, Hudson PJ, Howard MC, Pupovac A, Trounson AO, Boyd RL. Shu R, et al. Among authors: trounson ao. Mol Ther Oncolytics. 2021 Jan 16;20:325-341. doi: 10.1016/j.omto.2021.01.002. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33614914 Free PMC article.

8

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells.

Zhao W, Lei A, Tian L, Wang X, Correia C, Weiskittel T, Li H, Trounson A, Fu Q, Yao K, Zhang J. Zhao W, et al. Among authors: trounson a. iScience. 2020 Jun 26;23(6):101162. doi: 10.1016/j.isci.2020.101162. Epub 2020 May 17. iScience. 2020. PMID: 32502965 Free PMC article. Review.

9

Toward a Universal Solution: Editing Compatibility into Pluripotent Stem Cells.

Trounson A, Boyd NR, Boyd RL. Trounson A, et al. Cell Stem Cell. 2019 Apr 4;24(4):508-510. doi: 10.1016/j.stem.2019.03.003. Cell Stem Cell. 2019. PMID: 30951658 Free article.

10

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.

Ioannidis JPA, Kim BYS, Trounson A. Ioannidis JPA, et al. Among authors: trounson a. Nat Biomed Eng. 2018 Nov;2(11):797-809. doi: 10.1038/s41551-018-0314-y. Epub 2018 Nov 8. Nat Biomed Eng. 2018. PMID: 30931172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page